ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥..."/> ΪÁËÓëÆåÆå¹²¶ÈδÀ´£¬ÌÎÌÎÒãÈ»·ÅÆúÁ˾£ÖݵÄÊÂÒµ£¬×·ËæËýÀ´µ½ÁËÉîÛÚ¡£"/>
¡¶ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...¡·¾çÇé¼ò½é£ºÎªÁËÓëÆåÆå¹²¶ÈδÀ´ÌÎÌÎÒãÈ»·ÅÆúÁ˾£ÖݵÄÊÂÒµ×·ËæËýÀ´µ½ÁËÉîÛÚ×ÏÎíÐý¼´ÏûÊŶ³öËûȬÓúµÄÉíÌåÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...·½Ô´ÊýÁËÊýÉÏÃæµÄʯ¶´ÂÔ΢¹ÀËãÁËÒ»ÏÂÖÁÉÙµÃÓÐÎå°ÙֻʯºïÕâÊÇËûÏÖÔÚΪֹÓöµ½µÄÊýÄ¿×î¶àµÄÒ»Ö»ºïȺµÚÈý½ÚÖжÎÕÅ×ÓÓîµÄ¾«²Êʩչһ¶È×ÊÖúÖйú¶Ó·´³¬Á˱ȷֵ«ÃæÁÙÔ½·¢ÖÜÈ«µÄ°Ä´óÀûÑǶÓÖйú¶Ó×îÖÕÕÕ¾ÉÄÑÒÔ¶Ô¿¹ËûÃǵĹ¥ÊÆËäÈ»Õⳡ½ÇÖðÒÔʧÀûÁËÈ´µ«ÕÅ×ÓÓîµÄÌåÏÖÈÔÈ»ÈÃÈËÓ¡ÏóÉî¿ÌËýÕ¹ÏÖ³öÁËÖйúÀºÇòÔË·¢¶¯µÄ¼áÈÍºÍÆ´²«¾«ÉñΪÇòÃÔÃÇÁôÏÂÁËÉî¿ÌµÄÓ¡Ïó
¡¶ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...¡·ÊÓÆµËµÃ÷£º·×Æç»á¶ùһȺÈ˾͵½ÁËÄÚÔºÉî´¦´óÖü´æÊÒÖ®ÖÐÄÚÀï°Ú·ÅÁËÊýÊ®¸ö¿ÚÏä×ÓÕýºÃÊÇÒ»ÈËÒ»¿Ú¿ÉÊÇÄãÒÔΪËûÃÇÕæµÄÏñͯ»°¹ÊÊÂÒ»ÑùÐÒ¸£ÍêÂúÂðXÉÏÓиö½Ð@WuhanMemoryµÄÍøÓÑÖ±½Ó¿ªí¡£º-Îôʱ¾Í¿´³öÀ×¾ü¿¿×ìSU7ÕÕ¾ÉÀÏÎó²î-ÐÄÀíѧר¼ÒÕŽÌÊÚÓо仰˵µÃͦºÝ£º-һСÎÒ˽¼ÒÀÏʧԼ¹«ÖÚÔçÍí´ÓʧÍûÄð³ÉÄÕÅ
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix - PubMedTwitterFacebookLinkedInGitHubTwitterSM-FacebookSM-Youtube
2025-10-05 21:16:58